| Primary |
| Product Used For Unknown Indication |
36.6% |
| Drug Use For Unknown Indication |
31.7% |
| Urinary Incontinence |
5.7% |
| Hypertension |
3.5% |
| Hypertonic Bladder |
2.6% |
| Pain |
2.2% |
| Parkinson's Disease |
2.2% |
| Back Pain |
1.8% |
| Pollakiuria |
1.8% |
| Depression |
1.3% |
| Micturition Disorder |
1.3% |
| Micturition Urgency |
1.3% |
| Urge Incontinence |
1.3% |
| Urinary Tract Disorder |
1.3% |
| Bladder Spasm |
0.9% |
| Bronchitis |
0.9% |
| Diabetes Mellitus |
0.9% |
| Diarrhoea |
0.9% |
| Dysuria |
0.9% |
| Incontinence |
0.9% |
|
| Urinary Retention |
11.9% |
| Acne |
7.1% |
| Confusional State |
7.1% |
| Fall |
7.1% |
| Vomiting |
7.1% |
| Asthma |
4.8% |
| Chest Pain |
4.8% |
| Disorientation |
4.8% |
| Fatigue |
4.8% |
| Henoch-schonlein Purpura |
4.8% |
| Ileus |
4.8% |
| Nausea |
4.8% |
| Pregnancy |
4.8% |
| Somnolence |
4.8% |
| Visual Impairment |
4.8% |
| Abdominal Pain |
2.4% |
| Acute Hepatic Failure |
2.4% |
| Angioedema |
2.4% |
| Anticholinergic Syndrome |
2.4% |
| Arrhythmia |
2.4% |
|
| Secondary |
| Product Used For Unknown Indication |
27.9% |
| Hypertension |
10.2% |
| Parkinson's Disease |
8.2% |
| Hypertonic Bladder |
5.4% |
| Urinary Incontinence |
5.4% |
| Depression |
4.8% |
| Pain |
4.8% |
| Micturition Urgency |
4.1% |
| Back Pain |
3.4% |
| Acne |
2.7% |
| Dermatosis |
2.7% |
| Drug Use For Unknown Indication |
2.7% |
| Dyspepsia |
2.7% |
| Medical Diet |
2.7% |
| B-cell Lymphoma |
2.0% |
| Bipolar Disorder |
2.0% |
| Multiple Sclerosis |
2.0% |
| Neuralgia |
2.0% |
| Oedema Peripheral |
2.0% |
| Urge Incontinence |
2.0% |
|
| Pulmonary Embolism |
12.1% |
| Acne |
9.1% |
| Pancreatitis |
9.1% |
| Confusional State |
6.1% |
| Hepatic Enzyme Increased |
6.1% |
| Rhabdomyolysis |
6.1% |
| Stress |
6.1% |
| Transaminases Increased |
6.1% |
| Visual Impairment |
6.1% |
| Anxiety |
3.0% |
| Arrhythmia |
3.0% |
| Atrial Fibrillation |
3.0% |
| Blindness Transient |
3.0% |
| Breast Cancer Stage Ii |
3.0% |
| Cholelithiasis |
3.0% |
| Constipation |
3.0% |
| Cytolytic Hepatitis |
3.0% |
| Diarrhoea |
3.0% |
| Drug Ineffective |
3.0% |
| Dry Mouth |
3.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
37.3% |
| Multiple Sclerosis |
12.7% |
| Drug Use For Unknown Indication |
8.1% |
| Prophylaxis Against Renal Transplant Rejection |
7.4% |
| Depression |
4.6% |
| Rheumatoid Arthritis |
4.1% |
| Hypertension |
3.6% |
| Hypertonic Bladder |
2.7% |
| Dyspnoea |
2.2% |
| Anxiety |
1.9% |
| Atrial Fibrillation |
1.7% |
| Anaemia |
1.6% |
| Muscle Spasticity |
1.6% |
| Parkinson's Disease |
1.6% |
| Prophylaxis Against Transplant Rejection |
1.6% |
| Carcinoid Tumour |
1.5% |
| Prostatic Disorder |
1.5% |
| Hepatitis C |
1.4% |
| Hypothyroidism |
1.4% |
| Osteoporosis |
1.4% |
|
| Progressive Multifocal Leukoencephalopathy |
13.9% |
| Urinary Tract Infection |
8.7% |
| Erectile Dysfunction |
7.0% |
| Face Oedema |
7.0% |
| Tremor |
7.0% |
| Weight Increased |
7.0% |
| Constipation |
5.2% |
| Fall |
5.2% |
| Atrioventricular Block Second Degree |
4.3% |
| Urticaria |
4.3% |
| Vomiting |
4.3% |
| Dizziness |
3.5% |
| Off Label Use |
3.5% |
| Renal Failure |
3.5% |
| Alanine Aminotransferase Increased |
2.6% |
| Ankle Fracture |
2.6% |
| Convulsion |
2.6% |
| Drug Interaction |
2.6% |
| Hyperkalaemia |
2.6% |
| Muscular Weakness |
2.6% |
|
| Interacting |
| Drug Use For Unknown Indication |
50.0% |
| Back Pain |
25.0% |
| Urinary Incontinence |
25.0% |
|
|
